SERTRALINE

Product NDC
71610-769
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Sertraline
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Application
ANDA077397
Marketing category
ANDA
Substance
SERTRALINE HYDROCHLORIDE
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
71610-769-1515 TABLET, FILM COATED in 1 BOTTLE (71610-769-15) 2024-01-17NoHistorical
71610-769-3030 TABLET, FILM COATED in 1 BOTTLE (71610-769-30) 2024-03-07NoHistorical
71610-769-4545 TABLET, FILM COATED in 1 BOTTLE (71610-769-45) 2024-01-17NoHistorical
71610-769-5360 TABLET, FILM COATED in 1 BOTTLE (71610-769-53) 2024-01-17NoHistorical
71610-769-6090 TABLET, FILM COATED in 1 BOTTLE (71610-769-60) 2024-01-17NoHistorical
71610-769-73135 TABLET, FILM COATED in 1 BOTTLE (71610-769-73) 2024-01-17NoHistorical
71610-769-80180 TABLET, FILM COATED in 1 BOTTLE (71610-769-80) 2024-01-17NoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
SERTRALINEAphena Pharma Solutions - Tennessee, LLC2024-03-11HUMAN PRESCRIPTION DRUG LABEL2